Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PAVmed Inc. | 421,691 | reported | 08 Jun 2018 | tx 21+1,409,590−6,712,385 |
| Good Harbor Partners Acquisition Corp | 0 | reported | 18 Jun 2009 | tx 1−1,200,000 |
| Scopus BioPharma Inc. | 0 | reported | 23 Nov 2021 | tx 24+1,085,106−3,000,000 |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 12 buys in history.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Nov 2021 | OTHER | Scopus BioPharma Inc. | 3,000,000 | — | deriv |
| 27 Aug 2021 | PURCHASE | Scopus BioPharma Inc. | 110 | 4.92 USD | |
| 27 Aug 2021 | PURCHASE | Scopus BioPharma Inc. | 790 | 4.98 USD | |
| 24 Aug 2021 | PURCHASE | Scopus BioPharma Inc. | 50 | 4.65 USD | |
| 23 Aug 2021 | PURCHASE | Scopus BioPharma Inc. | 500 | 4.41 USD | |
| 20 Aug 2021 | PURCHASE | Scopus BioPharma Inc. | 400 | 4.23 USD | |
| 19 Aug 2021 | PURCHASE | Scopus BioPharma Inc. | 2,000 | 4.04 USD | |
| 18 Aug 2021 | PURCHASE | Scopus BioPharma Inc. | 1,000 | 4.27 USD | |
| 17 Aug 2021 | PURCHASE | Scopus BioPharma Inc. | 1,000 | 4.13 USD | |
| 31 Jul 2021 | OTHER | Scopus BioPharma Inc. | 1,068,016 | — | deriv |
| 26 Jul 2021 | PURCHASE | Scopus BioPharma Inc. | 1,000 | 4.78 USD | |
| 26 Jul 2021 | PURCHASE | Scopus BioPharma Inc. | 400 | 4.76 USD | |
| 27 Jul 2021 | PURCHASE | Scopus BioPharma Inc. | 200 | 4.54 USD | |
| 23 Jul 2021 | PURCHASE | Scopus BioPharma Inc. | 1,100 | 4.77 USD | |
| 24 Feb 2021 | PURCHASE | Scopus BioPharma Inc. | 115 | 9.48 USD | |
| 25 Feb 2021 | PURCHASE | Scopus BioPharma Inc. | 800 | 9.01 USD | |
| 24 Feb 2021 | PURCHASE | Scopus BioPharma Inc. | 300 | 9.45 USD | |
| 23 Feb 2021 | PURCHASE | Scopus BioPharma Inc. | 200 | 9.58 USD | |
| 23 Feb 2021 | PURCHASE | Scopus BioPharma Inc. | 1,300 | 9.66 USD | |
| 22 Feb 2021 | PURCHASE | Scopus BioPharma Inc. | 450 | 10.05 USD | |
| 18 Feb 2021 | PURCHASE | Scopus BioPharma Inc. | 2,200 | 10.04 USD | |
| 17 Feb 2021 | PURCHASE | Scopus BioPharma Inc. | 200 | 9.81 USD | |
| 17 Feb 2021 | PURCHASE | Scopus BioPharma Inc. | 475 | 9.69 USD | |
| 16 Feb 2021 | PURCHASE | Scopus BioPharma Inc. | 2,500 | 10.20 USD | first after silence |
| 08 Jun 2018 | SALE | PAVmed Inc. | 18,300 | 1.04 USD |
1 purchase reported after at least 12 months of silence — most recent on 16 Feb 2021.